{
  "Q0": "BRCA1/BRCA2 genetic testing for hereditary breast and ovarian cancer risk assessment",
  "Q1": "Yes",
  "Q2": "Not specified",
  "Q3": "Yes",
  "Q4": "Yes, NCCN",
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes, Yes",
  "Q10": "No, Risk Assessment",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Yes, 81162, 81163, 81164, 81165, 81166, 81167 (BRCA1/BRCA2 full sequence analysis and duplication/deletion analysis)",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "According to the policy, the following steps must be followed: 1) The provider must document the family history with special attention to breast and ovarian cancer, 2) Complete the 'Aetna Breast and Ovarian Cancer Susceptibility Gene Testing Prior Authorization Form', 3) Submit the form along with the Laboratory's Test Requisition Form to Aetna for precertification, 4) Include documentation of specific cancer diagnosis in the proband(s) and pertinent medical records, 5) Include a summary indicating how this testing will change the immediate medical care of the member, 6) The blood specimen should not be tested until confirmation of coverage is received and the test is precertified."
}